T2 Biosystems, Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/83a87f3a-2c3c-4cae-b232-6c6d9d682d63/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-49.7M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-039310 |
| FY 2022 | $-55.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011396 |
| FY 2021 | $-43.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011526 |
| FY 2020 | $-41.4M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-017074 |
| FY 2019 | $-52.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011217 |
| FY 2018 | $-45.1M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007862 |
| FY 2017 | $-53.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006225 |
| FY 2016 | $-50.9M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001853 |
| FY 2015 | $-43.4M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-003930 |
| FY 2014 | $-30.7M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-016705 |
| FY 2013 | $-19.7M | 2013-01-01 – 2013-12-31 | evidence 0001104659-15-016705 |
| FY 2012 | $-14.7M | 2012-01-01 – 2012-12-31 | evidence 0001104659-15-016705 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).